Clinical Trial: EMD and/or Bone Substitute for the Treatment of Class II Furcations

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Enamel Matrix Protein Derivative and/or Synthetic Bone Substitute for the Treatment of Mandibular Class II Buccal Furcation Defects. A 12-month Randomized Clinical Trial

Brief Summary: To clinically evaluate the treatment of mandibular class II furcation defects with enamel matrix derivative (EMD) and/or a bone substitute graft make of beta tricalcium phosphate/hydroxyapatite (βTCP/HA).